Clinical trials: Diseases Category
Lymphoma, Hodgkin Lymphoma (Category)
Rituximab in Treating Patients With Hodgkin's Lymphoma
Phase 2 trial to study the effectiveness of rituximab in treating patients who have lymphocyte-predominant Hodgkin's lymphoma.
- Conditions
- Lymphoma, Hodgkin Lymphoma (Category), Nodular Lymphocyte Predominant Hodgkin Lymphoma
- Trial name
- NCT00003820
- Testing
- Rituximab
- Where
- 2 sites in United States
- Volunteers
- 39 people
- Sponsor
- Ranjana Advani